Divi's Laboratories Ltd's shares fell nearly 3% on December 5, trading at Rs 6,078.6, after a US court ruled that Novartis could not block MSN Pharmaceuticals from launching a generic version of its heart drug, Entresto. The court upheld a previous decision that Novartis was unlikely to win a patent lawsuit against MSN, paving the way for the first US generic of the drug. Divi's Labs has a contract with Novartis for the drug, and its market capitalization stands at Rs 1.6 lakh crore.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.